INS and metabolic syndrome: Dietary nobiletin supplementation attenuates hepatic VLDL overproduction, ameliorates dyslipidemia, and prevents steatosis in HFD-fed Ldlr−/− mice by suppressing SREBP1c-mediated lipogenesis and enhancing fatty acid β-oxidation, thereby improving insulin sensitivity and glucose homeostasis [83].